ES2110454T3 - Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos. - Google Patents

Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.

Info

Publication number
ES2110454T3
ES2110454T3 ES92112431T ES92112431T ES2110454T3 ES 2110454 T3 ES2110454 T3 ES 2110454T3 ES 92112431 T ES92112431 T ES 92112431T ES 92112431 T ES92112431 T ES 92112431T ES 2110454 T3 ES2110454 T3 ES 2110454T3
Authority
ES
Spain
Prior art keywords
alkyl
compounds
low
aquire
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92112431T
Other languages
English (en)
Spanish (es)
Inventor
Werner Benson
Charldorp Karin Van
Peter Colin Gregory
Klaus-Ullrich Wolf
Ulf Preuschoff
Martin Tulp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2110454T3 publication Critical patent/ES2110454T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
ES92112431T 1991-07-31 1992-07-21 Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos. Expired - Lifetime ES2110454T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125292A DE4125292A1 (de) 1991-07-31 1991-07-31 6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES2110454T3 true ES2110454T3 (es) 1998-02-16

Family

ID=6437366

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92112431T Expired - Lifetime ES2110454T3 (es) 1991-07-31 1992-07-21 Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.

Country Status (21)

Country Link
US (1) US5272143A (enExample)
EP (1) EP0525584B1 (enExample)
JP (1) JP3174158B2 (enExample)
KR (1) KR930002353A (enExample)
CN (2) CN1069733A (enExample)
AT (1) ATE161012T1 (enExample)
AU (1) AU649153B2 (enExample)
CA (1) CA2075102A1 (enExample)
CZ (1) CZ239392A3 (enExample)
DE (2) DE4125292A1 (enExample)
ES (1) ES2110454T3 (enExample)
FI (1) FI923440A7 (enExample)
HU (2) HU211105B (enExample)
IE (1) IE922310A1 (enExample)
IL (1) IL102503A (enExample)
MX (1) MX9204457A (enExample)
NO (1) NO300375B1 (enExample)
NZ (1) NZ243715A (enExample)
RU (1) RU2078765C1 (enExample)
TW (1) TW207541B (enExample)
ZA (1) ZA925093B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414130A (en) * 1993-12-23 1995-05-09 The Dow Chemical Company Process for the preparation of diaminoresorcinol
EE05006B1 (et) * 1999-01-11 2008-04-15 Agouron Pharmaceuticals, Inc. Polü(ADP-riboos)polümeraaside tritsüklilised inhibiitorid ja neid sisaldavad farmatseutilised kompositsioonid
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
DK1794163T3 (da) * 2004-09-22 2010-04-12 Pfizer Fremgangsmåde til fremstilling af poly(ADP-ribose)polymeraseinhibitorer
RU2361592C2 (ru) * 2004-09-22 2009-07-20 Пфайзер Инк. Терапевтические комбинации, содержащие ингибитор поли(адф-рибоза)полимеразы
CN102046176B (zh) * 2008-05-29 2013-08-07 阿尔巴尼分子研究公司 5-ht3受体调节剂、其制备方法和用途
BR112012019050B1 (pt) * 2010-02-12 2021-12-21 Pfizer Inc Sal anidro de forma a do s-camsilato de 8-fluoro-2-{metilamino)metil]fenil}-1,3,4,5-tetra- hidro-6hazepino[5,4,3cd]indol-6-ona, composição e uso do mesmo
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
CA3106239A1 (en) 2018-07-27 2020-01-30 Biotheryx, Inc. Bifunctional compounds as cdk modulators
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
ATE161012T1 (de) 1997-12-15
MX9204457A (es) 1993-05-01
TW207541B (enExample) 1993-06-11
HU9202430D0 (en) 1992-10-28
FI923440A0 (fi) 1992-07-30
CN1141773A (zh) 1997-02-05
US5272143A (en) 1993-12-21
NZ243715A (en) 1995-03-28
FI923440A7 (fi) 1993-02-01
HU211105B (en) 1995-10-30
DE4125292A1 (de) 1993-02-04
CN1069733A (zh) 1993-03-10
AU649153B2 (en) 1994-05-12
NO300375B1 (no) 1997-05-20
CA2075102A1 (en) 1993-02-01
HUT65453A (en) 1994-06-28
IL102503A (en) 1995-12-31
EP0525584A1 (de) 1993-02-03
RU2078765C1 (ru) 1997-05-10
ZA925093B (en) 1993-04-28
NO923004L (no) 1993-02-01
DE59209055D1 (de) 1998-01-22
KR930002353A (ko) 1993-02-23
HU210217A9 (en) 1995-02-28
JPH05202052A (ja) 1993-08-10
IE922310A1 (en) 1993-02-10
JP3174158B2 (ja) 2001-06-11
CZ239392A3 (en) 1993-04-14
IL102503A0 (en) 1993-01-14
EP0525584B1 (de) 1997-12-10
AU2067792A (en) 1993-02-04
NO923004D0 (no) 1992-07-30

Similar Documents

Publication Publication Date Title
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
ATE40994T1 (de) L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
ES2046383T3 (es) Nuevos derivados de acidos difosfonicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2110454T3 (es) Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
ES2089672T3 (es) N-fenilacetaminonitrilos y su empleo como productos intermedios para la sintesis de 3-aril-pirrolidin-2,4-dionas insecticidas y acaricidas.
ES2078324T3 (es) Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen.
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
AR245933A1 (es) Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales.
ES2074323T3 (es) Nuevos derivados de piridilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2061580T3 (es) Compuestos de 3,7-diazabiciclo(3,3,1)nonano, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos.
ES2040366T3 (es) Procedimiento de preparacion de nuevos derivados de 1-(bencilpiperidino)2-propanol.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
CO4700291A1 (es) Compuestos quimicos
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
MX9301112A (es) Derivados de indol.
BR0109022A (pt) Método de preparação de citalopram e sua composição farmacêutica
ES2046218T3 (es) Derivados de acidos piridin-2,4- y -2,5-dicarboxilicos, procedimientos para su produccion, aplicacion de los mismos asi como medicamentos a base de estos compuestos.
ES2063475T3 (es) Procedimiento de fabricacion de bisfenol-a.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525584

Country of ref document: ES